PortalPublikationenMicroRNA Profiling of Alzheimer's Disease Cerebrospinal Flui...

MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid

Standard

MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid. / Denk, Johannes; Jahn, Holger.

Biomarkers for Alzheimer’s Disease Drug Development. Hrsg. / Robert G. Perneczky. Band 1750 1. Aufl. Humana Press, 2018. S. 93-107 (Methods in Molecular Biology; Band 1750).

Publikationen: SCORING: Beitrag in Buch/Sammelwerk › SCORING: Beitrag in Sammelwerk › Forschung › Begutachtung

Harvard

Denk, J & Jahn, H 2018, MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid. in RG Perneczky (Hrsg.), Biomarkers for Alzheimer’s Disease Drug Development. 1 Aufl., Bd. 1750, Methods in Molecular Biology, Bd. 1750, Humana Press, S. 93-107. https://doi.org/10.1007/978-1-4939-7704-8_6

APA

Denk, J., & Jahn, H. (2018). MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid. in R. G. Perneczky (Hrsg.), Biomarkers for Alzheimer’s Disease Drug Development (1 Aufl., Band 1750, S. 93-107). (Methods in Molecular Biology; Band 1750). Humana Press. https://doi.org/10.1007/978-1-4939-7704-8_6

Vancouver

Denk J, Jahn H. MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid. in Perneczky RG, Hrsg., Biomarkers for Alzheimer’s Disease Drug Development. 1 Aufl. Band 1750. Humana Press. 2018. S. 93-107. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7704-8_6

Bibtex

@inbook{0edbeea400ae49dca2232e850d900dfb,
title = "MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid",
abstract = "MicroRNAs (miRNAs) are a class of small, highly conserved, and noncoding RNAs that modulate gene expression by regulating the activity and stability of target mRNAs. MiRNAs play significant roles by controlling fundamental cellular processes and its deregulation is associated with various diseases. Ubiquitous expression and its release into circulation make them interesting biomarkers, which can be measured by different platforms. In this book chapter, we provide a specific protocol that describes the detection of circulating miRNAs in CSF by using RT-qPCR.",
keywords = "Journal Article",
author = "Johannes Denk and Holger Jahn",
year = "2018",
doi = "10.1007/978-1-4939-7704-8_6",
language = "English",
isbn = "978-1-4939-7703-1 Softcover ISBN",
volume = "1750",
series = "Methods in Molecular Biology",
publisher = "Humana Press",
pages = "93--107",
editor = "Perneczky, {Robert G.}",
booktitle = "Biomarkers for Alzheimer{\textquoteright}s Disease Drug Development",
address = "United States",
edition = "1",

}

RIS

TY - CHAP

T1 - MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid

AU - Denk, Johannes

AU - Jahn, Holger

PY - 2018

Y1 - 2018

N2 - MicroRNAs (miRNAs) are a class of small, highly conserved, and noncoding RNAs that modulate gene expression by regulating the activity and stability of target mRNAs. MiRNAs play significant roles by controlling fundamental cellular processes and its deregulation is associated with various diseases. Ubiquitous expression and its release into circulation make them interesting biomarkers, which can be measured by different platforms. In this book chapter, we provide a specific protocol that describes the detection of circulating miRNAs in CSF by using RT-qPCR.

AB - MicroRNAs (miRNAs) are a class of small, highly conserved, and noncoding RNAs that modulate gene expression by regulating the activity and stability of target mRNAs. MiRNAs play significant roles by controlling fundamental cellular processes and its deregulation is associated with various diseases. Ubiquitous expression and its release into circulation make them interesting biomarkers, which can be measured by different platforms. In this book chapter, we provide a specific protocol that describes the detection of circulating miRNAs in CSF by using RT-qPCR.

KW - Journal Article

U2 - 10.1007/978-1-4939-7704-8_6

DO - 10.1007/978-1-4939-7704-8_6

M3 - SCORING: Contribution to collected editions/anthologies

C2 - 29512067

SN - 978-1-4939-7703-1 Softcover ISBN

VL - 1750

T3 - Methods in Molecular Biology

SP - 93

EP - 107

BT - Biomarkers for Alzheimer’s Disease Drug Development

A2 - Perneczky, Robert G.

PB - Humana Press

ER -